Research Article
Antibodies against C1q Are a Valuable Serological Marker for Identification of Systemic Lupus Erythematosus Patients with Active Lupus Nephritis
Table 2
The presence of anti-C1q antibodies in patients with SLE (mean ± SD) (
).
| | | Active SLE () | Inactive SLE () | | | Anti-C1q positive | Anti-C1q negative | value | Anti-C1q positive | Anti-C1q negative | value |
| | Patient number (%) | 40/51 (78.4) | 11/51 (21.6) | NA | 10/44 (22.7) | 34/44 (77.3) | NA | | Gender (M/F) (% F) | 4/37 (89.2) | 2/9 (77.8) | NA | 1/9 (88.9) | 2/32 (93.8) | NA | | Ages (years) | 30.56 ± 8.21 | 30.89 ± 10.45 | 0.326 | 31.56 ± 11.37 | 34.44 ± 12.56 | 0.207 | | With LN number (%) | 29/51 (56.9) | 5/51 (9.8) | NA | 1/44 (2.3) | 0 | NA |
|
|
Active SLE disease was defined by SLEDAI score greater than 10. LN: lupus nephritis; M/F: male/female.
|
